文献速递前列腺癌

新型风险评分扩大低中危前列腺癌主动监测标准

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.
PubMed 文献 · BJU Int · 2018-06-03

结果显示采用18%阈值可使符合主动监测的患者比例从20.6%增至29.4%,且不增加误分类风险(与PRIAS标准相比)。

要点

  • 新风险评分纳入PSA、临床分期、活检分级分组、阳性针数和PSA密度。
  • 采用18%阈值较PRIAS标准可绝对增加10%的主动监测合格患者。
  • 该策略未增加根治术后不利病理特征的误分类风险。

核心结论

  • 使用新型风险评分选择主动监测可使合格患者比例绝对增加10%而不增加误分类风险。

研究设计与样本

  • 误分类定义为根治术后非器官局限或分级分组≥3。
  • 利用逻辑回归模型预测误分类并开发风险评分,系统分析不同阈值并与现有AS标准比较。

主要发现

  • 5289例(33.0%)患者存在不利病理特征。
  • 多变量分析显示PSA水平、临床分期、活检分级分组、阳性针数和PSA密度与不利疾病风险相关(均P < 0.001)。
  • PRIAS标准误分类风险为13%,低于其他标准;按PRIAS协议20.6%(3303例)患者合格。

关键数值与推荐

  • 采用风险评分18%阈值时,合格患者比例从20.6%增至29.4%,且误分类风险不高于PRIAS标准。

临床怎么用

  • 临床可考虑使用该新型风险评分以扩大主动监测的适用人群,同时保持较低的误分类风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a novel tool to increase the number of patients with prostate cancer eligible for active surveillance (AS) without increasing the risk of unfavourable pathological features (i.e., misclassification) at radical prostatectomy (RP). PATIENTS AND METHODS: Overall, 16 049 patients with low- or intermediate-risk prostate cancer treated with RP were identified. Misclassification was defined as non-organ confined or grade group ≥3 disease at RP. The coefficients of a logistic regression model predicting misclassification were used to develop a risk score. We then performed a systematic analysis of different thresholds to discriminate between patients with or without unfavourable disease and we compared it to available AS criteria. RESULTS: Overall, 5289 (33.0%) patients had unfavourable disease. At multivariable analyses, PSA level, clinical stage, biopsy grade group, the number of positive cores, and PSA density were associated with the risk of unfavourable disease (all P < 0.001). The Prostate Cancer Research International: Active Surveillance (PRIAS) criteria were associated with a lower risk of misclassification (13%) compared to other criteria. Overall, 3303 (20.6%) patients were eligible according to the PRIAS protocol. The adoption of an 18% threshold according to the risk score increased the proportion of eligible patients from 20.6% to 29.4% without increasing the risk of misclassification as compared to the PRIAS criteria. CONCLUSIONS: The use of a novel risk score for AS selection would result in an absolute increase of 10% in the number of patients eligible for this approach without increasing the risk of misclassification.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Gandaglia G, van den Bergh RCN, Tilki D, et al. How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator. BJU Int. 2018. PMID: 29772103. doi:10.1111/bju.14391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。